AGEN(AGEN)
AGEN
Q4 2026 EPS Estimate
$0.02
Nov 9, 2026 · Reports before open
Revenue Estimate
$35M
FY2026E EPS$0.78
Analyst Sentiment
Wall St. Consensus
Buy11 analysts·Moderate coverage
70
Score
9 Buy (82%)2 Hold (18%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
982%
Hold
218%
Sell
00%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$25.00
+226.4%
Consensus
$25.00
+226.4%
Bull
$25.00
+226.4%
12-Month Target Range11 analysts
$25.00$25.00$25.00
Current $7.66Consensus
Current Price
$7.66
Upside to Consensus
$17.34
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev-1.01%
EPS—
FY2028
Rev-6.70%
EPS—
FY2029
Rev-1.29%
EPS—
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $139M | $137M | $128M | $127M | $161M |
| Low | $137M | $137M | $126M | $126M | $161M |
| High | $140M | $137M | $130M | $127M | $162M |
| EBITDA Avg | $133M | $99M | $92M | $89M | $92M |
| Low | $129M | $91M | $85M | $89M | $92M |
| High | $137M | $102M | $99M | $89M | $92M |
| EBIT Avg | $121M | $85M | $77M | $74M | $75M |
| Low | $117M | $78M | $70M | $74M | $75M |
| High | $125M | $89M | $84M | $74M | $75M |
| Net Income Avg | $23M | $-5M | $-13M | $-17M | $-16M |
| Low | $20M | $-13M | $-20M | $-17M | $-16M |
| High | $26M | $-2M | $-6M | $-16M | $-16M |
| EPS Avg | $0.78 | $-0.24 | $-0.44 | $-0.56 | $-0.53 |
| Low | $0.68 | $-0.42 | $-0.68 | $-0.56 | $-0.53 |
| High | $0.86 | $-0.06 | $-0.20 | $-0.55 | $-0.52 |
| Analysts (Rev / EPS) | 1 / 1 | 2 / 1 | 2 / 2 | 1 / 1 | 1 / 1 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $35M | $36M | $29M | $29M | $29M | $29M |
| Low | $35M | $35M | $29M | $29M | $29M | $29M |
| High | $36M | $37M | $29M | $29M | $29M | $29M |
| EBITDA Avg | $16M | $15M | $-20M | $-21M | $-21M | $-20M |
| Low | $15M | $15M | $-21M | $-21M | $-21M | $-21M |
| High | $16M | $15M | $-20M | $-20M | $-21M | $-20M |
| EBIT Avg | $15M | $14M | $-22M | $-22M | $-22M | $-22M |
| Low | $14M | $14M | $-22M | $-23M | $-23M | $-22M |
| High | $16M | $14M | $-21M | $-22M | $-22M | $-22M |
| Net Income Avg | $-413,380 | $-1M | $-37M | $-37M | $-38M | $-37M |
| Low | $-826,760 | $-1M | $-37M | $-38M | $-38M | $-38M |
| High | $206,690 | $-1M | $-36M | $-37M | $-37M | $-37M |
| EPS Avg | $-0.01 | $-0.04 | $-0.89 | $-0.91 | $-0.91 | $-0.90 |
| Low | $-0.02 | $-0.04 | $-0.90 | $-0.92 | $-0.92 | $-0.91 |
| High | $0.01 | $-0.03 | $-0.88 | $-0.90 | $-0.90 | $-0.89 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |